Evidence of inhibiting effect of curcumin complex and aspirin combination in colorectal cancer: study

eec03b9c-27ed-4f21-9295-35f6627c2ca6articleimage.jpg

30 Oct 2017 --- Researchers have found evidence of the inhibitory effect in colon tumorigenesis of a low dose combination of aspirin and Sabinsa’s Curcumin C3 Complex. The findings have been published in the journal Biochemical Pharmacology.

Colorectal cancer (CRC) is one of the major causes of human mortality and morbidity. Colitis-accelerated colon cancer (CAC) is a sub-type of CRC that is also closely associated with inflammatory bowel disease (IBD). Although aspirin has been widely investigated as a chemopreventive agent for CAC and different types of CRC, the potential side-effect of gastrointestinal bleeding has been a concern in long-term high-dose aspirin therapy.  

In this new study on animals, researchers at Rutgers discovered that co-administration of Curcumin C3 Complex and aspirin helps to lower the dose of aspirin by 50 percent rendering this therapy feasible without adverse effects. It has been known earlier that Curcumin C3 complex is non-toxic at all tested doses.

Additionally, aspirin and C3 Complex combination modulated larger gene sets than the single agent treatment. These genes were involved in several canonical pathways important in the inflammatory network and liver metastasis in CAC. Also, this was the first study is first of its kind in an Azoxymethane(AOM)/DSS (Dextran sulfate sodium)-induced CAC.

“Extensive research on Curcumin C3 Complex continues to reveal additional applications and benefits, which fosters further studies added to the large body of science on C3 Complex,” says Sabinsa founder Dr. Muhammed Majeed. “The range of health benefits scientific investigation has identified continues to inspire researchers across the globe.”

At Vitafoods Asia 2017, NutritionInsight spoke with Sabinsa  CEO Shaheen Majeed about curcumin and other trending nutritionals. Curcumin, one of the natural compounds present in the turmeric rhizomes has been a focus of clinical investigations for management of several life style diseases or conditions such as Alzheimer, arthritis, liver disorders, hangovers, inflammation, hypercholesterolemia and asthma. With increasing research into biological functions and activities of curcumin, another area of curcumin biology is gaining a lot of attention – its metabolites

Earlier this month, Sabinsa’s parent company Sami Labs inaugurated a second Continuous Extraction Plant to meet the demand for Curcumin C3 Complex. This new facility will be exclusively used for curcumin extraction, increasing production of Curcumin C3 Complex to 25 tons from the previous capacity of 6 tons. The two Continuous Extraction units are spread across 5 acres in Dobaspet, Bangalore, India. 

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Nutrition & Health News

Targeting aching joints: A key theme at Vitafoods Europe 2018

21 May 2018 --- World populations are getting older and with age, the risk of bone and joint health issues – such as rheumatoid arthritis and osteoarthritis – increases. Moreover, joint health concerns also affect younger consumers, such as so-called “weekend warriors,” who exercise once or twice a week, meaning that the joint health market is of interest not just to senior citizens but also to any consumers seeking to live an active life. Among the different innovative healthy aging and lifestyle solutions presented at Vitafoods Europe this year, there was a clear spot for ingredients aimed at supporting joint health.

Nutrition & Health News

Key gut-brain interplays identified, enhancing possibilities for neurological treatments

21 May 2018 --- Steps have been taken toward untangling the complex interplay that allows the byproducts of microorganisms living in the gut to influence the progression of neurodegenerative diseases. Researchers have defined a pathway between the two, coined the gut-brain axis, that may help guide therapies for multiple sclerosis and other neurological diseases. Essentially, some gut microbes were found to activate an anti-inflammatory pathway that can limit neurodegeneration.

Nutrition & Health News

Sports nutrition mainstreams: A key theme at Vitafoods Europe 2018

18 May 2018 --- Boundaries are blurring as sports nutrition continues to move mainstream. Ingredients and products aimed at promoting active living were a clear standout theme at Vitafoods Europe this year. New launches targeted a wide scope of aspects related to active lifestyles, and are likely to resonate not just with hardcore athletes but also with consumers of different ages and activity groups. 

Nutrition & Health News

Weekly Digest: Valensa's Saw Palmetto gains sustainable logo

18 May 2018 --- The past week saw Valensa International gain sustainable recognition with the Fresh from Florida logo for their Saw Palmetto product, as well as USP’s (United States Pharmacopeia) Dietary Supplement Verification Program nabbing the top spot for reliability as determined by pharmacists in a survey conducted by the Pharmacy Times. Furthermore, in clinical news, omega 3 and omega 6 were found to aid the regulation of blood glucose levels in rats. The findings open up the potential for the use of supplements in type 2 diabetes regulation.

Nutrition & Health News

Glanbia targets modern lifestyle demands with new performance nutrition ingredients 

17 May 2018 --- Glanbia Nutritionals has launched two new performance nutrition ingredients for formulation in functional beverages in Europe, the Middle East and Africa. Ignitor and WheyXR were developed to enhance amino acid release, allowing manufacturers to maximize the health benefits of protein supplementation. Both ingredients target the ever-expanding market for sports nutrition options and were included in its range of prototypes at this year’s Vitafoods Europe 2018, which showcased Glanbia’s portfolio and applications expertise.

More Articles
URL : http://www.nutritioninsight.com:80/news/evidence-of-inhibiting-effect-of-curcumin-complex-and-aspirin-combination-in-colorectal-cancer-study.html